Clinical Trials - Phase II
Filter News
Found 29,785 articles
-
Northwestern Medicine Enrolls First Participant in Midwest for Research Study of Personalized Vaccine for Aggressive Brain Tumors
8/15/2013
-
Seattle Genetics, Inc. Announces Initiation of Phase 2 Trial of ADCETRIS® (Brentuximab Vedotin) in Combination With Current Standard of Care for Frontline Diffuse Large B-Cell Lymphoma (DLBCL)
8/15/2013
-
Johns Hopkins Hospital Joins Precision Biologics as a Collaborator on Phase 2A Pancreatic and Colorectal Cancer Trial
8/15/2013
-
Chimerix, Inc. Anti-Infection Drug Fails Phase 2
8/14/2013
-
Immunomedics, Inc. Release: Epratuzumab and Rituximab Produce High Rate and Durable Progression-Free Survival in Previously Untreated Follicular Lymphoma
8/14/2013
-
Ultragenyx Pharmaceuticals Receives Approval of Clinical Trial Application (CTA) for a Phase 1/2 Trial Testing UX003 in Mucopolysaccharidosis Type 7 (MPS 7)
8/14/2013
-
Prima Biomed's "CANVAS" Clinical Trial Approved to Start in Korea
8/14/2013
-
Dance Biopharma Announces Encouraging Clinical Data for Adagio™-- Inhalable Insulin Product Candidate for Diabetes
8/13/2013
-
Merrimack Pharmaceuticals Inc.l's MM-111 Granted Orphan Drug Status by FDA For Treatment of Advanced Gastric and Esophageal Cancers
8/13/2013
-
Acasti Pharma Announces Positive Phase II Open Label Clinical Trial Results
8/13/2013
-
Immunomedics, Inc. Advances Solid Tumor Antibody-Drug Conjugate Programs to Phase II Clinical Trials
8/12/2013
-
Celldex Therapeutics, Inc. Announces Expansion of Phase 2 ReACT Study in Recurrent Glioblastoma
8/12/2013
-
Eli Lilly and Company's Type 1 Diabetes Drug Strikingly Effective in Clinical Trial
8/9/2013
-
Threshold Pharmaceuticals, Inc. Initiates Phase 2 Study of TH-302 in Patients With Advanced Melanoma
8/8/2013
-
Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) Announces Publication of Eteplirsen Clinical Study Results in the Annals of Neurology
8/8/2013
-
gIcare Pharma Initiates Phase 2a Study of Its Lead Product, GIC-1001, in Sedation-Free Analgesia for Colorectal Cancer Screening
8/7/2013
-
Synta Pharmaceuticals Release: Interim Results of the GALAXY-1 Trial to be Presented at Best of American Society of Clinical Oncology
8/7/2013
-
Synergy Pharmaceuticals Announces Positive End-of-Phase 2 Meeting With FDA for Plecanatide in Chronic Idiopathic Constipation
8/5/2013
-
Sorrento Therapeutics, Inc. and IGDRASOL Proceed with Development of Cynviloq™ under 505(b)(2) Bioequivalence Regulatory Pathway
8/5/2013
-
Halozyme Therapeutics, Inc. Plummets as Its Partner ViroPharma Incorporated Discontinues Phase 2 Trial
8/2/2013